Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Pricing snapshots
Regulatory databases
Product category trackers
Regulatory reports
Market reports
Infographics
Market Snapshots
News analysis
Flavour & nicotine trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • United States House committee accuses CTP of ‘fostering uncertainty’…
  • Slovenia Consultation ends on bill to ban flavours…
  • Germany Notifications list updated…
  • Louisiana - United States Bill aims to ban all flavours bar tobacco…
  • Brazil Banned or legal? Status of e-cigs to be settled ‘this year’…
  • Germany Untaxed e-liquids seized after retailers’ transitional period ends…
  • Egypt Health ministry warns strongly against e-cigarettes…
  • Netherlands Figures show sharp rise in vaping by young people…
  • United States Juul and Altria face trial over alleged marketing of e-cigs to kids…
  • Switzerland Study reveals level of e-cig use by 15-year-olds…
  • Egypt Ramadan suggested as good opportunity to quit tobacco…
  • Egypt Senate passes bill that could place further restrictions on e-cigs…
View all
News analysis

The FDA’s new philosophy: ‘We need to take a fresh look at nicotine’

Written by || 31st July 2017 || News analysis || Health and science | Policy and Politics | Regulation and Legislation | North America United States

Scott Gottlieb, commissioner of the US Food and Drug Administration (FDA), appeared on Friday to go further than any federal official – or most politicians – previously had in supporting alternative nicotine products for harm reduction. ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

FDA extends PMTA deadline by nearly four years
Court rejects Nicopure’s attempt to overturn deeming regulations
No relief from deeming regs as US Senate approves key spending bill